
|Articles|February 1, 2004
- LCGC North America-02-01-2004
- Volume 22
- Issue 2
Investigating Out-of-Specification Results
This column discusses potential sources and ways to avoid out-of-specification (OOS) results and highlights the draft FDA guidelines on OOS investigations.
Advertisement
Articles in this issue
about 22 years ago
From the Editorabout 22 years ago
Pittcon Product Showcaseabout 22 years ago
Peaks of Interestabout 22 years ago
Debating Resolution and Mass Accuracyabout 22 years ago
Selecting the Best Curve Fitabout 22 years ago
Developments in 2-D Gas Chromatography with Heartcuttingabout 22 years ago
CalendarNewsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Advertisement
Advertisement
Advertisement
Trending on LCGC International
1
Mass Spectrometry–Driven Strategies for Membrane Protein–Targeted Drug Discovery
2
Thermo Fisher and NVIDIA Partner to Expand AI Driven Laboratory Automation
3
Isotope Dilution HPLC–MS/MS Analysis of Serum Cotinine Reveals Environmental Tobacco Smoke–Associated PID Risk
4
Ep. 43: An Introduction to Optical Photothermal Infrared (O-PTIR) Spectroscopy
5




